Australia is closely awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://jeanughh207966.muzwiki.com/554329/this_new_drug_retatrutide_australia_a_potential_hope_for_weight_management